Digital Health Deals on Track to Pass 2015

So far in 2016, eHealth is only four deals away from surpassing 2015’s total of 126, and nearly $20 billion has been spent (out of 20 disclosed prices). Nine deals have been announced in September, most of which exemplify how eHealth touches many areas of healthcare, beyond the expected revenue cycle management (RCM), electronic health records (EHR) etc. On September 15, 2016, privately-held RightEye LLC, a provider of eye-tracking technology that captures and scores eye movements and helps to predict, evaluate and improve outcomes of its users, purchased rights to two eye movement tests from the University of California, San Diego, and Virginia Commonwealth University. The GeoPref Autism... Read More »

Second Quarter Health Care M&A Spending Tanks

It’s still early yet, but we can say with confidence that the second quarter of 2015 doesn’t hold a candle to last year’s second quarter, at least dollar-wise. Last year, deal volume and value hit all-time highs for all previous Q2s, coming in at 325 deals and $135.8 billion in spending on those deals. This year, deal volume was fairly steady at 312 (remember, these are preliminary figures for Q2:15) but deal value plummeted 60% to $54.2 billion. We’ll have more details in the July issue of Health Care M&A News, but in the meantime, here are the biggest deals of Q2:15.  Read More »

Independent Welch Allyn Sells for $2.05 Billion

Welch Allyn, Inc. was a quiet, family-run global medical device company, based in the Finger Lakes region of New York State. We knew the peace couldn’t last. Sure enough, last week Hill-Rom Holdings, Inc. (NYSE: HRC) agreed to pay $2.05 billion for the Skaneateles Falls-based company that makes those physical examination instruments and accessories you so look forward to seeing whenever you visit your doctor. It also makes EMR-connected vital signs and cardiac monitoring devices, with the aid of 2,600 people in 26 countries. Hill-Rom Holdings operates as a medical technology company, and its financial advisors at Goldman, Sachs & Co. expect this transaction to generate $2.6 billion in... Read More »